121 related articles for article (PubMed ID: 38538524)
1. miR-215-5p Plays a Key Role in Suppressing Vascular Invasion and Recurrence in Hepatocellular Carcinoma by Blocking Vasculogenic Mimicry.
Zhang H; Lan X; Cai L; Gao X; Gao F; Yu D; Zhang J; Zhang J; Tai Q
Front Biosci (Elite Ed); 2024 Feb; 16(1):6. PubMed ID: 38538524
[TBL] [Abstract][Full Text] [Related]
2. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
3. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
Jiang G; Wen L; Deng W; Jian Z; Zheng H
Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884
[TBL] [Abstract][Full Text] [Related]
4. Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma.
Qin X; Zhang J; Lin Y; Sun XM; Zhang JN; Cheng ZQ
J Transl Med; 2020 Aug; 18(1):326. PubMed ID: 32859232
[TBL] [Abstract][Full Text] [Related]
5. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
6. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
Yan TH; Qiu C; Sun J; Li WH
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
8. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
[TBL] [Abstract][Full Text] [Related]
9. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
11. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
14. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression.
Qian X; Wang Y; Hu W; Xu X; Gao L; Meng Y; Yan J
Tissue Cell; 2022 Feb; 74():101721. PubMed ID: 34979376
[TBL] [Abstract][Full Text] [Related]
15. miR-671-5p Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma through Targeting ALDH2.
Chen X; Luo J; Gao S; Jiang J; Yang B; Zhang Z
Crit Rev Eukaryot Gene Expr; 2022; 32(4):73-82. PubMed ID: 35695667
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
17. Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT.
Zhang N; Zhang S; Wu W; Lu W; Jiang M; Zheng N; Huang J; Wang L; Liu H; Zheng M; Wang J
Mol Carcinog; 2021 Feb; 60(2):151-163. PubMed ID: 33428809
[TBL] [Abstract][Full Text] [Related]
18. miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT.
Li W; Jiang Y; Pan Q; Yang G
Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA ZEB2-AS1 Promotes Hepatocellular Carcinoma Progression by Regulating The
Wu SM; Chen J; Liang Y; Luo Q; Tong YY; Xie L
Cell J; 2022 Jun; 24(6):285-293. PubMed ID: 35892230
[TBL] [Abstract][Full Text] [Related]
20. miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1.
Wang L; Cui M; Cheng D; Qu F; Yu J; Wei Y; Cheng L; Wu X; Liu X
Mol Cell Biochem; 2021 Feb; 476(2):575-583. PubMed ID: 33106914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
